tiprankstipranks
Springworks Therapeutics (SWTX)
NASDAQ:SWTX
US Market

Springworks Therapeutics (SWTX) Income Statement

Compare
407 Followers

Springworks Therapeutics Income Statement

Last quarter (Q4 2024), Springworks Therapeutics's total revenue was $61.55M, an increase of 1029.96% from the same quarter last year. In Q4, Springworks Therapeutics's net income was $-77.30M. See Springworks Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 191.59M$ 5.45M$ 6.15M$ 0.00$ 35.00M
Gross Profit
$ 179.04M$ 5.03M$ 4.25M$ -490.00K$ 34.65M
Operating Expenses
$ 457.17M$ 348.04M$ 280.67M$ 173.47M$ 81.32M
Depreciation and Amortization
$ 0.00$ 1.67M$ 1.90M$ 490.00K$ 349.00K
EBITDA
$ -278.13M$ -341.35M$ -280.67M$ -172.98M$ -45.98M
Operating Income
$ -278.13M$ -343.01M$ -280.67M$ -173.47M$ -46.32M
Other Income/Expenses
$ 20.00M$ 17.91M$ 3.26M$ -442.00K$ 750.00K
Pretax Income
$ -258.13M$ -325.10M$ -277.42M$ -173.91M$ -45.57M
Net Income
$ -258.13M$ -325.10M$ -274.16M$ -173.21M$ -44.24M
Per Share Metrics
Basic EPS
$ -3.48$ -5.15$ -5.14$ -3.57$ -1.02
Diluted EPS
$ -3.48$ -5.15$ -5.14$ -3.57$ -1.02
Weighted Average Shares Outstanding
74.13M 63.12M 53.29M 48.50M 43.30M
Weighted Average Shares Outstanding (Diluted)
74.13M 63.12M 53.29M 48.50M 43.30M
Currency in USD

Springworks Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis